Latest News Archive

Please select Category, Year, and then Month to display items

Xhosa Student Association and GEADO host dialogue about gender-based violence

05 September 2023 | Story Nicole Bongo | Photo Supplied

GBV dialogue 2023 — The UFS Xhosa Student Association and Gender Equality and Anti-Discrimination Office joined forces to host a dialogue to enlighten students on combating gender-based violence.

The Xhosa Student Association at the University of the Free State (UFS), along with the UFS Gender Equality and Anti-Discrimination Office (GEADO) on its Bloemfontein Campus, recently hosted a dialogue titled ‘Aiding the Victim’, to educate students about what perpetuates gender-based violence, and inform them about UFS support services available to help fight GBV.

The discussion was held at the Education Auditorium on 25 August 2023, and students were challenged to pinpoint what GBV is and what it looks like. Balisa Nqambuza, Chairperson of the Xhosa Student Association and second-year BA student majoring in psychology and philosophy, said, “There is a need to have these tough conversations, as they provide insight on how to combat GBV in the future... We have had enough talks about the problem, and it is very important to start speaking about solutions that inform people of what they can do when encountering GBV.”

The event organisers said the dialogue was an opportunity for GEADO and the Xhosa Student Association to inform students about support structures within the university that provide help for students through free counselling sessions.

“The objective was to bring awareness about GBV victims amongst us, and how to assist them better, and to also highlight comprehensive approaches, as dialogues may discuss holistic approaches that address the multidimensional impact of GBV, including psychological, emotional, physical, and economic consequences,” said Pebetsi Kgole, a guest speaker and intern from GEADO.

In May 2023, the United Nations International Children's Emergency Fund reported a shocking rise in violence against women in South Africa, with 969 murders and 1 485 attempted murders recorded over this period. The UFS has put many structures in place to help in the fight against the scourge of GBV.

Other support services available include a sexual offense response team made up of GEADO, Protection Services, Kovsie Health, access to psychologists and social workers, and free services to help victims feel safe in a secure environment.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children

2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept